Larvol Delta - Horizontal-Combination-of-MEK-and-PI3KmTOR-Inhibition-in-BRAF-Mutant-Tumor-Cells-with-or-without-Concomitant-PI3K-Pathway-Mutations

dactolisib (RTB101) - resTORbio

Koselugo (selumetinib) - Merck (MSD), AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/33081092

Oct 23, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next